PSMA diagnostics and treatments of prostate cancer become mature.
作者信息
von Eyben Finn Edler, Baumann Glenn Stewart, Baum Richard Paul
机构信息
Center for Tobacco Control Research, Birkevej 17, 5230 Odense M, Denmark.
2Deparment of Radiation Oncology, University of Western Ontario in London, London, ON Canada.
出版信息
Clin Transl Imaging. 2018;6(2):145-148. doi: 10.1007/s40336-018-0270-2. Epub 2018 Mar 7.
Abstract
摘要
相似文献
1
PSMA diagnostics and treatments of prostate cancer become mature.前列腺癌的前列腺特异性膜抗原（PSMA）诊断和治疗已臻成熟。
Clin Transl Imaging. 2018;6(2):145-148. doi: 10.1007/s40336-018-0270-2. Epub 2018 Mar 7.
2
Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.68Ga-PSMA HBED-CC PET 对生化复发前列腺癌患者淋巴结转移评估的价值：与挽救性淋巴结切除术后组织病理学的比较。
J Nucl Med. 2016 Nov;57(11):1713-1719. doi: 10.2967/jnumed.116.173492. Epub 2016 Jun 3.
3
Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CT.使用 68Ga-HBED-CC-PSMA PET/CT 对转移性分化型甲状腺癌中前列腺特异性膜抗原表达进行成像。
Clin Nucl Med. 2017 Jan;42(1):20-25. doi: 10.1097/RLU.0000000000001454.
4
68Ga-PSMA-HBED-CC PET/CT imaging in Black versus White South African patients with prostate carcinoma presenting with a low volume, androgen-dependent biochemical recurrence: a prospective study.68Ga-PSMA-HBED-CC PET/CT成像在南非黑人和白人前列腺癌患者低容量雄激素依赖性生化复发中的应用：一项前瞻性研究
Nucl Med Commun. 2018 Feb;39(2):179-185. doi: 10.1097/MNM.0000000000000791.
5
Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer.[68Ga]Ga-PSMA-HBED-CC 的新型临床前和放射性药物学研究：一种用于前列腺癌成像的新型 PET 示踪剂。
Pharmaceuticals (Basel). 2014 Jun 30;7(7):779-96. doi: 10.3390/ph7070779.
6
Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.复发前列腺癌患者中[(18)F]DCFPyL与[(68)Ga]Ga-PSMA-HBED-CC用于PSMA-PET成像的比较
Mol Imaging Biol. 2015 Aug;17(4):575-84. doi: 10.1007/s11307-015-0866-0.
7
Intrapatient Comparison of 111In-PSMA I&T SPECT/CT and Hybrid 68Ga-HBED-CC PSMA PET in Patients With Early Recurrent Prostate Cancer.患者内比较 111In-PSMA I&T SPECT/CT 和 68Ga-HBED-CC PSMA PET 混合显像在早期复发性前列腺癌患者中的应用。
Clin Nucl Med. 2016 Sep;41(9):e397-402. doi: 10.1097/RLU.0000000000001273.
8
Integrated Ga-HBED-CC-PSMA-PET/MRI in patients with suspected recurrent prostate cancer.整合镓-六氮杂环十二烷四羧酸-环糊精-前列腺特异性膜抗原正电子发射断层扫描/磁共振成像在疑似复发性前列腺癌患者中的应用
Nuklearmedizin. 2017 Jun 13;56(3):73-81. doi: 10.3413/Nukmed-0850-16-09. Epub 2017 Apr 12.
9
Extent of disease in recurrent prostate cancer determined by [(68)Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score.通过[（68）Ga]PSMA-HBED-CC PET/CT测定的复发性前列腺癌疾病范围与PSA水平、PSA倍增时间和 Gleason评分的关系
Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):397-403. doi: 10.1007/s00259-015-3240-1. Epub 2015 Nov 12.
10
Detection rate of PET/CT in patients with biochemical relapse of prostate cancer using [Ga]PSMA I&T and comparison with published data of [Ga]PSMA HBED-CC.使用[镓]PSMA I&T检测前列腺癌生化复发患者中PET/CT的检出率，并与[镓]PSMA HBED-CC的已发表数据进行比较。
Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):670-677. doi: 10.1007/s00259-016-3572-5. Epub 2016 Nov 28.
引用本文的文献
1
Prognostic value of baseline alkaline phosphatase of 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.177Lu-PSMA放射性配体疗法中基线碱性磷酸酶对转移性去势抵抗性前列腺癌的预后价值：一项系统评价和荟萃分析
PLoS One. 2024 Dec 12;19(12):e0307826. doi: 10.1371/journal.pone.0307826. eCollection 2024.
2
Cyclotron Production of Gallium-68 Radiopharmaceuticals Using the Zn(p,n)Ga Reaction and Their Regulatory Aspects.使用锌（p，n）镓反应回旋加速器生产镓-68放射性药物及其监管方面。
Pharmaceutics. 2022 Dec 26;15(1):70. doi: 10.3390/pharmaceutics15010070.
3
Nano-Theranostics for the Sensing, Imaging and Therapy of Prostate Cancers.用于前列腺癌传感、成像和治疗的纳米诊疗学
Front Chem. 2022 Apr 12;10:830133. doi: 10.3389/fchem.2022.830133. eCollection 2022.
4
Promise and challenges of clinical non-invasive T-cell tracking in the era of cancer immunotherapy.癌症免疫治疗时代临床非侵入性T细胞追踪的前景与挑战。
EJNMMI Res. 2022 Jan 31;12(1):5. doi: 10.1186/s13550-022-00877-z.
5
Evolving Castration Resistance and Prostate Specific Membrane Antigen Expression: Implications for Patient Management.不断演变的去势抵抗和前列腺特异性膜抗原表达：对患者管理的影响
Cancers (Basel). 2021 Jul 16;13(14):3556. doi: 10.3390/cancers13143556.
6
A Systematic Review and Meta-analysis of the Effectiveness and Toxicities of Lutetium-177-labeled Prostate-specific Membrane Antigen-targeted Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer.镥-177 标记前列腺特异性膜抗原靶向放射性配体治疗在转移性去势抵抗性前列腺癌中的疗效和毒性的系统评价和荟萃分析。
Eur Urol. 2021 Jul;80(1):82-94. doi: 10.1016/j.eururo.2021.03.004. Epub 2021 Apr 8.
7
Diagnostic Role of F-PSMA-1007 PET/CT in Prostate Cancer Staging: A Systematic Review.F-PSMA-1007 PET/CT在前列腺癌分期中的诊断作用：一项系统评价
Diagnostics (Basel). 2021 Mar 19;11(3):552. doi: 10.3390/diagnostics11030552.
8
Performance of fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography imaging for lymph node staging in bladder and upper tract urothelial carcinoma: a systematic review.氟代脱氧葡萄糖正电子发射断层扫描-计算机断层扫描成像在膀胱和上尿路尿路上皮癌淋巴结分期中的应用：一项系统评价
Arab J Urol. 2020 Dec 10;19(1):59-66. doi: 10.1080/2090598X.2020.1858012.
9
Nanobodies Targeting Prostate-Specific Membrane Antigen for the Imaging and Therapy of Prostate Cancer.靶向前列腺特异性膜抗原的纳米抗体用于前列腺癌的成像和治疗。
J Med Chem. 2020 Jul 23;63(14):7601-7615. doi: 10.1021/acs.jmedchem.0c00418. Epub 2020 Jun 8.
10
Size Matters: Arginine-Derived Peptides Targeting the PSMA Receptor Can Efficiently Complex but Not Transfect siRNA.尺寸很重要：靶向前列腺特异性膜抗原（PSMA）受体的精氨酸衍生肽能有效结合但不能转染小干扰RNA（siRNA）。
Mol Ther Nucleic Acids. 2019 Dec 6;18:863-870. doi: 10.1016/j.omtn.2019.10.013. Epub 2019 Oct 23.
本文引用的文献
1
Third-line treatment and Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review.三线治疗和 Lu-PSMA 放射性配体疗法治疗转移性去势抵抗性前列腺癌：系统评价。
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):496-508. doi: 10.1007/s00259-017-3895-x. Epub 2017 Dec 16.
2
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial.寡转移前列腺癌复发的监测或转移灶导向治疗：一项前瞻性、随机、多中心 II 期试验。
J Clin Oncol. 2018 Feb 10;36(5):446-453. doi: 10.1200/JCO.2017.75.4853. Epub 2017 Dec 14.
3
Salvage lymph node dissection after Ga-PSMA or F-FEC PET/CT for nodal recurrence in prostate cancer patients.镓-前列腺特异性膜抗原（Ga-PSMA）或氟-氟乙基半胱氨酸（F-FEC）PET/CT检查后对前列腺癌患者淋巴结复发进行挽救性淋巴结清扫术。
Oncotarget. 2017 Sep 21;8(48):84180-84192. doi: 10.18632/oncotarget.21118. eCollection 2017 Oct 13.
4
Prostate cancer-specific PET radiotracers: A review on the clinical utility in recurrent disease.前列腺癌特异性 PET 放射性示踪剂：在复发性疾病中的临床应用综述。
Pract Radiat Oncol. 2018 Jan-Feb;8(1):28-39. doi: 10.1016/j.prro.2017.07.011. Epub 2017 Jul 20.
5
Intermediate-term outcome after PSMA-PET guided high-dose radiotherapy of recurrent high-risk prostate cancer patients.PSMA-PET 引导下高危前列腺癌复发患者高剂量放疗的中期结果。
Radiat Oncol. 2017 Aug 23;12(1):140. doi: 10.1186/s13014-017-0877-x.
6
The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients.前列腺特异性膜抗原正电子发射断层扫描（PSMA PET/CT）引导放疗在寡转移前列腺癌患者中的可行性。
Clin Transl Oncol. 2018 Apr;20(4):484-490. doi: 10.1007/s12094-017-1736-9. Epub 2017 Aug 9.
7
Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.Ga 标记前列腺特异性膜抗原配体正电子发射断层扫描/计算机断层扫描在前列腺癌中的应用：系统评价和荟萃分析。
Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15.
8
Treatment Outcomes from Ga-PSMA PET/CT-Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET.根治性前列腺切除术后 PSA 升高男性患者接受 Ga-PSMA PET/CT 引导下挽救性放射治疗的疗效：PSMA PET 阴性的预后价值
J Nucl Med. 2017 Dec;58(12):1972-1976. doi: 10.2967/jnumed.117.196683. Epub 2017 Jul 26.
9
Initial multicentre experience of gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited.镓-PSMA PET/CT引导下机器人辅助挽救性淋巴结清扫术的初步多中心经验：安全性可接受，但肿瘤学获益似乎有限。
BJU Int. 2017 Nov;120(5):673-681. doi: 10.1111/bju.13919. Epub 2017 Jun 20.
10
Ga-PSMA Ligand PET/CT-based Radiotherapy for Lymph Node Relapse of Prostate Cancer After Primary Therapy Delays Initiation of Systemic Therapy.基于镓-前列腺特异性膜抗原（Ga-PSMA）配体正电子发射断层扫描/计算机断层扫描（PET/CT）的放射治疗对前列腺癌初次治疗后淋巴结复发患者全身治疗起始的延迟作用
Anticancer Res. 2017 Mar;37(3):1273-1279. doi: 10.21873/anticanres.11444.
Zotero 插件